CuringHeartDisease

Always searching for a cure
Peter Megdal, PhD
Join Our Cause

Revised: July 16, 2026

LDL “BAD” Cholesterol: Apolipoprotein B, Imaging Resolution, and the Illusion of “Normal” Coronary Arteries at Age 60

By: Peter Megdal PhD

How to Use This Article

Choose your format
Easy Read
Deep Dive
YouTube
SPOTIFY
SLIDE DECK
  • Based on peer-reviewed medical research
  • Same evidence cardiologists use
  • Written in clear language for the public
  • Look for underlined terms and related links

Medical disclaimer: This article is for education only and is not medical advice. Always consult your clinician for personal guidance.

Easy Read

The Mystery of the “Perfect” 60-Year-Old

Imagine a man named John who just turned 60. John feels great. He goes for walks, eats his greens, and can still keep up with his grandkids. He recently went to his doctor for a big check-up. The doctor looked at his charts, checked his blood pressure, and gave him a “normal” report. His tests didn’t show any big clogs, and his cholesterol numbers looked “fine.” John left the office feeling like he had the heart of a teenager.

However, John might be caught in “The Check-up Mystery.” This is a situation where the tests look good on the surface, but the reality inside the body is much different.

Think of it like an old house built 60 years ago. From the sidewalk, the house looks amazing. It has a fresh coat of bright paint and a perfect lawn. But if you were to rip open the walls, you might find old, rusty pipes and wires that are starting to fray. The house looks “normal” to anyone passing by, but the structure is aging deep where no one can see.

This post is here to show you why common heart tests often miss the “hidden” dangers of heart disease. We are going to look at why a clean bill of health might just be a trick and what the science really says about our arteries as we grow older.

Takeaway 1: Your Arteries Started Aging When You Were a Teenager

Most people think heart disease is an “old person” problem. They believe that if they are 30 or 40 years old, their arteries are “perfectly clean under a microscope.” But medical research shows a very different, and much more honest, story.

There is a huge gap between what a doctor sees on a standard test (which we call Clinical Reality) and what a scientist sees when they look at the body’s tissues directly (which we call Forensic Reality). Scientists have looked at the arteries of teenagers and young adults who passed away in accidents. Two famous studies, the “PDAY” study and the “Bogalusa Heart Study,” found something that should change how we think about our health.

Almost all of those teenagers already had the very first signs of heart disease. Scientists call these “fatty streaks.” These are tiny yellow piles of fat that start to build up in the lining of the heart’s pipes.

Analysis and Reflection: It is a shock to realize that “perfect” arteries basically do not exist in the Western world by the time someone reaches age 40. We spend our lives thinking we are starting with a clean slate every time we go for a run or eat a salad. But the “trash” has been piling up since we were in high school. By the time someone is 60, the idea that their arteries are “undamaged” is almost always a mistake made by tests that just aren’t powerful enough. As the experts say:

“By the sixth decade of life, perfectly clean coronary arteries are virtually absent in Western populations.”

Takeaway 2: LDL is the Wrong Way to Count Your Risk

When you get a blood test, your doctor usually looks at “LDL-C.” This measures the weight of the “bad” cholesterol in your blood. But science is finding that weight isn’t the best way to measure danger. Instead, we should be looking at “ApoB.”

To understand this, let’s use an analogy of suitcases and passengers.

Imagine a doorway (your artery wall). LDL-C is like the total weight of all the luggage coming through the airport. But ApoB is the actual number of suitcases. It doesn’t matter if a suitcase is heavy or light; if there are too many suitcases, they are going to get stuck in the doorway and cause a pile-up.

Every single “bad” particle that causes heart disease has exactly one ApoB protein on it. This makes ApoB a much more accurate way to count the “particle burden”—the actual number of things that can get stuck in your heart’s pipes.

The Power of Time (ApoB-Years): It isn’t just about how many “suitcases” you have today. It’s about how long they have been trying to get through the door. Scientists call this “ApoB-years.” Having high ApoB for 40 years is much more dangerous than having it for 5 years. It’s like a slow-dripping faucet; over many years, even a small drip can flood a basement.

Lipoprotein Metric What it Measures Why it Matters
LDL-C (Weight) The total mass or weight of cholesterol. Can be wrong if you have many small particles.
ApoB (Count) The actual number of “bad” particles. The strongest predictor of risk; tells you the true “burden.”
Lp(a) (Sticky) A special, extra-sticky particle. An independent risk factor that makes clots more likely.

Takeaway 3: The “Glagov Effect” – How Your Arteries Hide the Trash

Why do doctors often miss this buildup? It’s because of something called the “Glagov Effect.”

Think of your artery like a walk-in closet. As you start to shove more and more “junk” (plaque) into the closet, you don’t just let it block the door right away. Instead, you push the back wall of the closet out further into the next room. To someone looking through the doorway, the closet looks empty and clear. But in reality, the walls are bulging with hidden junk.

Your arteries do the same thing. When plaque builds up, the outer layer of the artery wall actually stretches outward. This keeps the “hallway” (where the blood flows) wide open.

Analysis and Reflection: This is why standard tests like angiograms fail us. They only look at the open space where blood flows. They cannot see the plaque hidden inside the “bulging” walls. In fact, your arteries can be 40% full of plaque before the blood flow even starts to slow down. By the time a standard test sees a “clog,” the disease has been growing for decades. We have been looking at the “hallway” while the “walls” are filled with trash.

Takeaway 4: Why a “Zero” Calcium Score Isn’t a “Get Out of Jail Free” Card

Many people get a test called a Coronary Artery Calcium (CAC) score. This test looks for “hard” plaque—plaque that has turned into calcium, which is like bone. If your score is zero, you might think you have zero risk.

But a “zero” score does not mean you have zero plaque. It just means you don’t have calcified plaque.

The Healing Paradox: This is the part that surprises many people. Calcium is actually a sign of “plaque healing.” It is like a scar that the body uses to cover a wound. When the body sees a mess in the artery, it tries to “stone it over” to make it stable.

  1. Hard Plaque: This is old, scarred, and calcified. It is the body’s way of trying to fix the problem.
  2. Soft Plaque: This is young, “greasy” plaque. It is much more dangerous because it is “biologically active” and unstable.

Think of soft plaque like a pimple. If it “pops” (ruptures), it causes a sudden blood clot, which leads to a heart attack. Hard plaque is actually less likely to pop. Data shows that 25% to 30% of heart attacks happen to people who had a calcium score of zero.

Analysis and Reflection: A zero score is better than a high score, but it is a “snapshot in time.” It shows you where the body has already created scars. It tells you nothing about the “soft grease” currently building up in your walls. For someone with high ApoB, a zero score usually just means the damage hasn’t turned to “stone” yet. The fire is still burning; it just hasn’t left any ashes for the scan to see.

Takeaway 5: AI is Smarter Than the Human Eye

Doctors are very smart, but they are limited by what the human eye can see on a screen. New technology called “AI-QCT” (like the Cleerly platform) is changing the game. This technology uses Artificial Intelligence to look at heart scans much more closely than a human can.

In a study of 750 patients, doctors looked at scans and identified 159 people they thought had “no plaque” at all. They looked “clean.” However, when the AI looked at the exact same scans, it found that many of those people actually had hidden plaque.

  • Human Eye: 159 people were told they had “no plaque.”
  • AI Eye: Only 58 of those people actually had no plaque.

The AI found that 101 people whom doctors thought were “clean” actually had non-calcified plaque (the dangerous “soft” kind). The AI can “quantify” (measure the exact amount) and “characterize” (see what it’s made of) the plaque better than a human. It shows that standard visual checks by doctors almost always miss how much disease is actually there.

Takeaway 6: The “MINOCA” Warning – Heart Attacks Without Blockages

We often think a heart attack only happens when a pipe is 100% blocked, like a clogged drain in a sink. But there is a condition called “MINOCA.” This happens when someone has a heart attack even though their pipes look wide open.

This accounts for about 5% to 15% of all heart attacks.

How does this happen? It happens because even a small, “soft” bump of plaque can tear. When that happens, the body tries to fix the tear by forming a blood clot. That clot is what stops the heart, even if the artery itself looked “open” just moments before.

Analysis and Reflection: This is the most frightening part of the “illusion.” You could have a “normal” report on Monday and a heart attack on Tuesday because a tiny, hidden bump of soft plaque decided to pop. Imagine the fear of a patient being told their “pipes are clear” only to end up in the emergency room a week later. This is why keeping your “particle count” (ApoB) low is the best defense. The fewer “suitcases” you have, the less likely you are to have one of these small but deadly “bumps” form in the first place.

Summary: Beyond the Illusion

We need to stop thinking about heart disease as a “clogged pipe” problem that only happens to old people. Instead, we need to see it as a lifelong process of “particle buildup.”

The “Clean Artery” illusion happens because our tools are often not powerful enough to see the early stages of the disease. We might have wide-open “hallways” in our arteries, but the “walls” could be filled with decades of hidden plaque.

Age vs. Plaque: The Reality Gap

Age Group “Clean” results on Clinical Scans Likely “Pristine” Arteries in Reality (Autopsy)
61–75 Years 28% to 40% of people look “clean” ~0% (Almost nobody is truly clean)
75–85 Years 10% to 20% of people look “clean” ~0% (Almost nobody is truly clean)
90+ Years ~5% of people look “clean” ~0% (Almost nobody is truly clean)

Final Thought: Next time you talk to your doctor about your heart, don’t just settle for a “normal” report. You should ask a deeper question: “Doctor, my tests look normal, but what is my ApoB count, and how do we know I don’t have hidden soft plaque?” Understanding your true “particle burden” and the hidden state of your artery walls could save your life by spotting the danger before the “illusion” disappears.

Deep Dive

Apolipoprotein B, Imaging Resolution, and the Illusion of “Normal” Coronary Arteries at Age 60

The clinical assertion that individuals maintaining markedly elevated levels of low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B (ApoB) can possess anatomically “normal” coronary arteries at age 60 represents a diagnostic paradox. This phenomenon often hinges on the resolution of the imaging tool used. While contemporary tools like the Coronary Artery Calcium (CAC) score and standard visual Coronary Computed Tomography Angiography (CCTA) provide a high-resolution window into the arterial wall, they exist in tension with pathological evidence which suggests that atherosclerosis is a nearly universal condition of human aging, and clinical data showing that heart attacks can occur even in the absence of significant anatomical blockages [1].

The Causal Framework of Lipoprotein-Driven Atherogenesis

The consensus establishes that prolonged exposure to ApoB-containing lipoproteins is the primary driver of atherosclerotic plaque [2]. Each atherogenic particle—including LDL, VLDL, and IDL—carries a single molecule of ApoB, making it a direct measure of the total number of circulating particles that can penetrate the arterial wall [2]. The probability of a particle becoming trapped in the subendothelial space is a function of both particle concentration and the duration of exposure, often quantified as “ApoB-years” [2].

While LDL-C measures the mass of cholesterol, ApoB reflects the particle burden [3]. In cases of discordance—where ApoB is high but LDL-C is relatively lower—ApoB remains the more accurate predictor of future myocardial infarction (MI) and clinical events [4].

Lipoprotein Metrics

Lipoprotein Metric Definition and Pathological Role Association with Plaque Burden
Low-Density Lipoprotein Cholesterol (LDL-C) The mass of cholesterol contained within LDL particles Causal, but may be discordant with particle count [3]
Apolipoprotein B (ApoB) A structural protein; one exists on every atherogenic particle Strongest predictor of risk; reflects true particle burden [3]
Lipoprotein(a) [Lp(a)] An LDL-like particle with an additional protein [apo(a)] Independent risk factor; promotes calcification and thrombosis [5]

Forensic vs. Clinical Reality: The “Pristine” Artery Illusion

The claim that an individual can reach age 60 without “arterial damage” is often a result of clinical imaging failing to detect microscopic disease. Forensic autopsy studies, including the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) and the Bogalusa Heart Study, demonstrate that microscopic fatty streaks—the earliest macroscopic evidence of atherosclerosis—are present in nearly all adolescents examined [6].

By the sixth decade of life, pathologically pristine coronary arteries are virtually absent in Westernized populations. Diffuse intimal thickening and lipid deposition become ubiquitous by midlife, and contemporary autopsy cohorts report coronary atherosclerosis in nearly all adults by the fourth decade [6].

The Glagov Effect: How Arteries Hide Plaque Burden

A critical contributor to “normal” coronary imaging is the Glagov phenomenon, or compensatory outward remodeling [7]. As plaque accumulates within the arterial wall, the vessel expands externally to preserve luminal diameter and maintain blood flow [7]. Hemodynamically significant luminal narrowing is typically delayed until plaque burden exceeds approximately 40% of the internal elastic lamina area [7].

Because standard invasive angiography and conventional visual CCTA focus primarily on the lumen, substantial plaque burden may exist within the vessel wall while remaining angiographically invisible [7]. These concealed plaques are often lipid-rich and biologically active, rendering them prone to erosion or rupture capable of precipitating MI even in the absence of pre-existing stenosis [1].

AI-QCT (Cleerly) vs. Standard Visual Interpretation

Artificial Intelligence–Quantitative Computed Tomography (AI-QCT) platforms, such as Cleerly, have demonstrated that standard visual interpretation of CCTA systematically underestimates plaque burden [8]. By enabling volumetric plaque quantification and compositional analysis, AI-QCT achieves accuracy approaching invasive intravascular ultrasound [8].

In a cohort of approximately 750 patients, AI-QCT analysis led to diagnostic modification in 39% of cases, while the number of patients classified as having “no plaque” fell from 159 to 58 following quantitative assessment [8]. These findings confirm that visually “normal” coronary CT angiograms frequently harbor clinically relevant non-calcified plaque.

Coronary Artery Calcium Score and Myocardial Infarction Risk

Coronary Artery Calcium scoring is a powerful population-level risk stratification tool, but its relationship with individual myocardial infarction risk is probabilistic rather than absolute. Large prospective cohorts, including the Multi-Ethnic Study of Atherosclerosis (MESA), demonstrate a strong graded association between CAC burden and future coronary heart disease events, with markedly elevated risk observed at scores ≥300 [11].

However, a CAC score of zero does not confer immunity from MI. Although short-term event rates are low, non-calcified, lipid-rich plaques—particularly in individuals with elevated ApoB—remain capable of rupture or erosion [12]. Approximately 25–30% of acute coronary syndromes occur in individuals with absent or minimal coronary calcification at baseline, reflecting the temporal disconnect between plaque formation, calcification, and plaque instability [12]. Calcification is increasingly recognized as a marker of plaque chronicity and healing rather than vulnerability, whereas non-calcified plaque burden correlates more closely with near-term risk.

Thus, CAC scoring is best interpreted as a measure of cumulative plaque burden and long-term risk rather than as a detector of biologically active atherosclerosis. In high–ApoB individuals, a CAC score of zero more likely reflects delayed disease expression than true disease absence.

MI Risk With “Near-Zero” Plaque Burden: The MINOCA Syndrome

Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) accounts for approximately 5–15% of all acute myocardial infarctions [1]. Even small, non-obstructive plaques may undergo endothelial erosion, triggering localized thrombosis without angiographically visible obstruction [9].

Importantly, ApoB remains a strong independent predictor of MI risk even among individuals without obstructive coronary disease, as demonstrated in large population cohorts and randomized lipid-lowering trials [4].

Longitudinal Data: Prevalence of Zero Plaque From 60 to 100 Years

Despite near-universal atherosclerosis on pathological examination, clinical imaging registries identify a subset of individuals who maintain zero coronary calcification into advanced age [10].

Age Group (Years) Prevalence of CAC = 0 (Clinical Imaging) Likelihood of Truly “Pristine” Arteries (Autopsy)
61–75 28%–40% ~0%
75–85 10%–20% ~0%
≥90 ~5% ~0%

In the oldest old, a so-called “cholesterol paradox” has been observed, wherein higher LDL-C levels (≥130 mg/dL) are sometimes associated with longer survival, likely reflecting survival bias or age-dependent protective roles of cholesterol in immune function and cellular repair [10].

References

  1. Tamis-Holland JE, Jneid H, Reynolds HR, et al. Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association. Circulation. 2019;139(18):e891-e908. doi:10.1161/CIR.0000000000000670
  2. Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38(32):2459-2472. doi:10.1093/eurheartj/ehx144
  3. Sniderman AD, Thanassoulis G, Glavinovic T, et al. Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiol. 2019;4(12):1287-1295. doi:10.1001/jamacardio.2019.3780
  4. Marston NA, Giugliano RP, Melloni GEM, et al. Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis: Distinguishing Between Particle Concentration, Type, and Content. JAMA Cardiol. 2022;7(3):250-256. doi:10.1001/jamacardio.2021.5083
  5. Tsimikas S. A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies. J Am Coll Cardiol. 2017;69(6):692-711. doi:10.1016/j.jacc.2016.11.042
  6. Strong JP, Malcom GT, McMahan CA, et al. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA. 1999;281(8):727-735. doi:10.1001/jama.281.8.727
  7. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316(22):1371-1375. doi:10.1056/NEJM198705283162204
  8. Nurmohamed NS, Cole JH, Budoff MJ, et al. Impact of atherosclerosis imaging-quantitative computed tomography on diagnostic certainty, downstream testing, coronary revascularization, and medical therapy: the CERTAIN study. Eur Heart J Cardiovasc Imaging. 2024;25(6):857-866. doi:10.1093/ehjci/jeae029
  9. Agewall S, Beltrame JF, Reynolds HR, et al. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart J. 2017;38(3):143-153. doi:10.1093/eurheartj/ehw149
  10. Mortensen MB, Nordestgaard BG. Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70-100 years: a contemporary primary prevention cohort. Lancet. 2020;396(10263):1644-1652. doi:10.1016/S0140-6736(20)32233-9
  11. Budoff MJ, Shaw LJ, Liu ST, et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol. 2007;49(18):1860-1870. doi:10.1016/j.jacc.2006.10.079
  12.  Blaha MJ, Cainzos-Achirica M, Greenland P, et al. Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2016;133(9):849-858. doi:10.1161/CIRCULATIONAHA.115.018524

Transparency Note: This blog post was created with assistance from AI tools. The final content has been carefully reviewed and edited by the author, who is responsible for its accuracy. The information provided is for educational purposes only and does not constitute medical advice.

Editorial and AI Transparency statement

Share This Post

Related Articles

Watch on YouTube
AI App

Heart Risk Calulator

Educational family-history heart risk calculator with H-score insights, visual family tree input and shareable PDF reports.

Read why this app is so important here.